A nationwide recall has been issued in the United States for certain batches of children’s liquid ibuprofen after reports of contamination, including the "presence of a gel-like substance and black particles." The recall involves products distributed by Strides Pharma Inc. and manufactured in India for Taro Pharmaceuticals.
The recalled product is:
Children’s Ibuprofen Oral Suspension, USP, 100 mg per 5 milliliters
Packaged in 4-fluid-ounce bottles
The affected lots are 7261973A and 7261974A, with an expiration date of Jan. 31, 2027.
According to reports, nearly 90,000 have been affected and removed from circulation as a precautionary measure.
See also: Cipla USA Recalls Nilotinib Cancer Drug After USFDA Warning
The recall was initiated following consumer complaints to the Strides Inc. describing:
Presence of a gel-like mass in the liquid formulation
Detection of black particulate matter
Such contamination may indicate issues in manufacturing, storage, or product stability, raising concerns about product quality and safety.
The recall is classified as Class II by FDA.
A Class II drug recall is a designation used by the U.S. Food and Drug Administration to indicate a potential health risk associated with a medication. It applies to products that may cause temporary or medically reversible adverse effects, with a low likelihood of serious harm.
This intermediate-level classification helps protect public health while distinguishing such cases from the more urgent Class I recalls. Class II recalls commonly involve issues such as reduced drug potency, manufacturing defects, or labeling errors that could affect the safe and effective use of the medication.
While no widespread adverse health effects have been reported so far, contaminated liquid medications may pose risks such as:
Incorrect dosing due to altered consistency
Potential ingestion of foreign particles
Reduced effectiveness of the medication
Parents and caregivers are advised to check product batches and avoid using affected bottles.
See also: MAR-Amlodipine Recall 2026: Health Canada Warns of Midodrine Mix-Up
Ibuprofen is a commonly used nonsteroidal anti-inflammatory drug (NSAID) indicated for:
Fever reduction
Pain relief (e.g., teething, minor injuries)
Inflammation control
Liquid formulations are widely used in pediatric populations due to ease of administration and dosing flexibility.
The recalled product was:
Manufactured in India
Distributed in the United States by Strides Pharma Inc.
Produced for Taro Pharmaceuticals
Global pharmaceutical supply chains often involve manufacturing in one country and distribution in another, requiring strict quality control at multiple levels.
Consumers who have purchased the affected product should:
Stop using the medication immediately
Check recall notices for batch numbers
Contact healthcare providers if any unusual symptoms occur
Follow official guidance for product return or disposal
The recall of children’s liquid ibuprofen in the United States highlights the importance of quality assurance in pharmaceutical manufacturing and supply chains. Regulatory monitoring and prompt recalls remain critical to ensuring medication safety, particularly for pediatric populations.
(Rh)